Dexmedetomidine: Increased risk of mortality in intensive care unit (ICU) patients ≤65 years
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Dexdor
|
| Active substance |
Dexmedetomidine hydrochloride
|
| Therapeutic area (MeSH) |
Conscious Sedation
|
| Procedure number |
EMEA/H/C/002268/II/0035
|
| Regulatory outcome |
Maintenance
|
| DHPC type |
Safety signal
|
| Human ATC code |
N05CM18
|
| Dissemination date |
16/06/2022
|